Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Rating
Sector Rating
Recommendation *
Avoid
Neutral
Fair
Quality
Rating Breakdown
Avg.
Relative Strength
The relative strength of a dividend stock indicates whether the stock is uptrending or not. The major determining factor in this rating is whether the stock is trading close to its 52-week-high.
Overall Yield Attractiveness
If a stock’s yield is above or near the market average then it will be rated higher within this parameter. High dividend yields (usually over 10%) should be considered extremely risky, while low dividend yields (1% or less) are simply not very beneficial to long-term investors.
Dividend Reliability
A stock’s dividend reliability is determined by a healthy payout ratio that is higher than other stocks. A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future.
Dividend Uptrend
A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase.
Earnings Growth
A stock’s Earnings Growth rating evaluates a company’s expected EPS for the current financial year and compares it to next financial year’s expected EPS. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates.
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Invesco DWA Healthcare Momentum ETF
ETF
PTH
Payout Change
Suspended
Price as of:
$35.27
-0.02
-0.06%
primary theme
Health Care Sector Equity
PTH (ETF)
Invesco DWA Healthcare Momentum ETF
Payout Change
Suspended
Price as of:
$35.27
-0.02
-0.06%
primary theme
Health Care Sector Equity
PTH (ETF)
Invesco DWA Healthcare Momentum ETF
Payout Change
Suspended
Price as of:
$35.27
-0.02
-0.06%
primary theme
Health Care Sector Equity
Name
As of 09/19/2023Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-14.0%
1 yr return
-15.9%
3 Yr Avg Return
-7.9%
5 Yr Avg Return
1.8%
Net Assets
$165 M
Holdings in Top 10
56.9%
52 WEEK LOW AND HIGH
$35.3
$35.15
$126.75
Expenses
OPERATING FEES
Expense Ratio 0.71%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 09/19/2023Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
PTH - Profile
Distributions
- YTD Total Return -14.0%
- 3 Yr Annualized Total Return -7.9%
- 5 Yr Annualized Total Return 1.8%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.32%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameInvesco DWA Healthcare Momentum ETF
-
Fund Family NameINVESCOETF
-
Inception DateOct 12, 2006
-
Shares Outstanding2020000
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerPeter Hubbard
Fund Description
The Fund generally will invest at least 90% of its total assets in securities that comprise the Underlying Index.
Strictly in accordance with its guidelines and mandated procedures, Dorsey, Wright & Associates, LLC (“Dorsey Wright” or the “Index Provider”) compiles and maintains the Underlying Index, which is composed of at least
30 securities of companies in the health care sector that have powerful relative strength or “momentum” characteristics. Dorsey Wright selects these securities from approximately 2,000 of the largest constituents by market capitalization within the Nasdaq US Benchmark™ Index, a float adjusted market capitalization-weighted index designed to track the performance of the U.S. equity market. “Relative strength” is an investing technique that seeks to determine the strongest performing securities by measuring certain factors, such as a security’s relative performance against the overall market over a set period or a security’s relative strength value, which is derived by comparing the rate of increase of the security’s price as compared to that of a benchmark index.
The Index Provider uses a proprietary methodology to analyze the relative strength of each security within the universe of eligible securities and determine a “momentum” score. In general, momentum is the tendency of an investment to exhibit persistence in its relative performance; a “momentum” style of investing emphasizes investing in securities that have had better recent performance compared to other securities. The momentum score for each security included in the Underlying Index is based on intermediate and long-term price movements of the security as compared to a representative benchmark and other eligible securities within the Underlying Index universe.
After giving each eligible security a momentum score, the Index Provider selects at least 30 securities with the highest momentum scores from the health care sector, as determined by the Index Provider, for inclusion in the Underlying Index. Companies in the health care sector are principally engaged in the business of providing health care-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities.
The total number of securities in the Underlying Index may vary depending on the capitalization characteristics of the securities that qualify for inclusion in the Underlying Index. The Index Provider weights each security by its momentum score, with higher scoring securities representing a greater weight in the Underlying Index.
As of June 30, 2023, the Underlying Index was comprised of 44constituents with market capitalizations ranging from $494 million to $201.3 billion.
The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.
Concentration Policy. The Fund will concentrate its investments (i.e., invest 25% or more of the value of its total assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of April 30, 2023, the Fund had significant exposure to the health care sector. The Fund’s portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.
PTH - Performance
Return Ranking - Trailing
| Period | PTH Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -14.0% | -15.4% | 11.9% | 96.32% |
| 1 Yr | -15.9% | -31.1% | 9.0% | 96.93% |
| 3 Yr | -7.9%* | -23.7% | 8.5% | 92.31% |
| 5 Yr | 1.8%* | -15.3% | 10.9% | 84.96% |
| 10 Yr | 9.4%* | -6.8% | 14.2% | 67.92% |
* Annualized
Return Ranking - Calendar
| Period | PTH Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | -20.6% | -53.9% | 3.2% | 85.90% |
| 2021 | -3.2% | -39.6% | 24.2% | 64.74% |
| 2020 | 67.3% | -13.6% | 178.2% | 1.32% |
| 2019 | 34.4% | 3.8% | 63.8% | 8.89% |
| 2018 | -1.2% | -25.3% | 21.5% | 27.13% |
Total Return Ranking - Trailing
| Period | PTH Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -14.0% | -15.1% | 12.0% | 96.32% |
| 1 Yr | -15.9% | -30.9% | 12.4% | 96.93% |
| 3 Yr | -7.9%* | -21.6% | 15.3% | 92.31% |
| 5 Yr | 1.8%* | -11.6% | 11.5% | 84.96% |
| 10 Yr | 9.4%* | 1.5% | 14.8% | 67.92% |
* Annualized
Total Return Ranking - Calendar
| Period | PTH Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2022 | -20.6% | -53.9% | 3.7% | 89.10% |
| 2021 | -3.2% | -33.9% | 26.0% | 83.33% |
| 2020 | 67.3% | 3.0% | 180.6% | 3.31% |
| 2019 | 34.4% | 4.6% | 63.8% | 20.74% |
| 2018 | -1.2% | -20.6% | 22.2% | 55.81% |
PTH - Holdings
Concentration Analysis
| PTH | Category Low | Category High | PTH % Rank | |
|---|---|---|---|---|
| Net Assets | 165 M | 5.09 M | 28 B | 67.48% |
| Number of Holdings | 48 | 25 | 473 | 84.81% |
| Net Assets in Top 10 | 103 M | 1.78 M | 21.6 B | 65.19% |
| Weighting of Top 10 | 56.91% | 12.3% | 80.8% | 10.76% |
Top 10 Holdings
- Invesco Private Prime Fund 16.96%
- Prometheus Biosciences, Inc. 6.67%
- Invesco Private Government Fund 6.60%
- Lantheus Holdings, Inc. 4.38%
- Reata Pharmaceuticals, Inc., Class A 4.08%
- Thermo Fisher Scientific Inc. 4.05%
- IVERIC bio, Inc. 4.02%
- IDEXX Laboratories, Inc. 3.71%
- Apellis Pharmaceuticals, Inc. 3.39%
- HCA Healthcare, Inc. 3.05%
Asset Allocation
| Weighting | Return Low | Return High | PTH % Rank | |
|---|---|---|---|---|
| Stocks | 100.02% | 85.37% | 106.13% | 2.53% |
| Cash | 23.71% | -0.04% | 9.01% | 1.90% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 48.10% |
| Other | 0.00% | -22.99% | 3.38% | 58.86% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 46.84% |
| Bonds | 0.00% | 0.00% | 12.39% | 44.30% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | PTH % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 23.42% |
| Utilities | 0.00% | 0.00% | 0.00% | 42.41% |
| Technology | 0.00% | 0.00% | 22.69% | 46.84% |
| Real Estate | 0.00% | 0.00% | 5.89% | 44.94% |
| Industrials | 0.00% | 0.00% | 7.02% | 46.20% |
| Financial Services | 0.00% | 0.00% | 1.60% | 60.76% |
| Energy | 0.00% | 0.00% | 0.00% | 42.41% |
| Communication Services | 0.00% | 0.00% | 9.11% | 45.57% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 50.00% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 44.94% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 61.39% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | PTH % Rank | |
|---|---|---|---|---|
| US | 100.02% | 53.67% | 104.41% | 1.90% |
| Non US | 0.00% | 0.00% | 45.40% | 90.51% |
PTH - Expenses
Operational Fees
| PTH Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.71% | 0.08% | 33.47% | 74.05% |
| Management Fee | 0.50% | 0.03% | 1.25% | 14.72% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| PTH Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| PTH Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| PTH Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 238.00% | 95.81% |
PTH - Distributions
Dividend Yield Analysis
| PTH | Category Low | Category High | PTH % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 1.90% | 53.99% |
Dividend Distribution Analysis
| PTH | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Quarterly | Annually | Quarterly | Annually |
Net Income Ratio Analysis
| PTH | Category Low | Category High | PTH % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.32% | -2.54% | 1.85% | 57.69% |
Capital Gain Distribution Analysis
| PTH | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 31, 2013 | $0.011 | OrdinaryDividend |
| Sep 30, 2013 | $0.008 | OrdinaryDividend |
| Jun 28, 2013 | $0.111 | OrdinaryDividend |
| Dec 31, 2012 | $0.327 | OrdinaryDividend |
| Jun 29, 2012 | $0.025 | OrdinaryDividend |
| Dec 31, 2009 | $0.058 | OrdinaryDividend |
| Jun 30, 2009 | $0.025 | OrdinaryDividend |
PTH - Fund Manager Analysis
Managers
Peter Hubbard
Start Date
Tenure
Tenure Rank
Jun 01, 2007
15.01
15.0%
Peter Hubbard, Vice President and Director of Portfolio Management of the Invesco PowerShares Capital Management LLC. Mr. Hubbard has been a Portfolio Manager of the Adviser since June 2007 and has been associated with the Adviser since 2005. Prior to joining the Invesco PowerShares Capital Management LLC, Hubbard was a research analyst and trader for Ritchie Capital from September 2003 to May 2005.
Michael Jeanette
Start Date
Tenure
Tenure Rank
Aug 31, 2008
13.76
13.8%
Michael Jeanette, Senior Portfolio Manager of Invesco Capital Management LLC, has been associated with Invesco Capital Management LLC since 2008. Prior to joining Invesco Capital Management LLC, Mr. Jeanette was a trust advisor and GM of Chicago based Richard Lamb, LLC from 1998 to 2007.
Tony Seisser
Start Date
Tenure
Tenure Rank
Aug 29, 2014
7.76
7.8%
Tony Seisser is a Vice President and Portfolio Manager of Invesco PowerShares Capital Management LLC since December 2013. Prior to joining the Adviser, he was employed by Guggenheim Funds Distributors, Inc. where he was a trader from 2010 to 2013. Prior to that, Mr. Seisser was a compliance investigator at the Chicago Board of Options Exchange and Chicago Futures Exchange from 2008 to 2010.
Pratik Doshi
Start Date
Tenure
Tenure Rank
Aug 28, 2020
1.76
1.8%
Pratik Doshi is a Portfolio Manager of Invesco Capital Management. Mr. Doshi has been a Portfolio Manager of Invesco Capital Management since October 2019 and has been associated with Invesco Capital Management since 2018. Prior to joining Invesco Capital Management, Mr. Doshi was a business student in the MBA program at the University of Chicago from 2016 to 2018. From 2014 to 2016, he served as a Vice President at Bank of America, and from 2007 to 2014 he served as Assistant Vice President at Barclays Capital.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.84 | 0.25 |
